While diagnosing possibility of TTP, the PLASMIC score developed by Bendapudi et al.19 is a useful predictive tool for assessing the likelihood of severe ADAMTS13 deficiency in patients with TMA. This evidence concerns the gene ADAMTS13 and hyperinsulinemic hypoglycemia, familial, 4.